These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7214016

  • 21. Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
    Olivieri NF, Koren G, Hermann C, Bentur Y, Chung D, Klein J, St Louis P, Freedman MH, McClelland RA, Templeton DM.
    Lancet; 1990 Nov 24; 336(8726):1275-9. PubMed ID: 1978115
    [Abstract] [Full Text] [Related]

  • 22. Reassessment of the use of desferrioxamine B in iron overload.
    Propper RD, Shurin SB, Nathan DG.
    N Engl J Med; 1976 Jun 24; 294(26):1421-3. PubMed ID: 1272274
    [Abstract] [Full Text] [Related]

  • 23. Iron chelation in red cell ghosts.
    Smith GN.
    Lancet; 1981 Jan 24; 1(8213):222-3. PubMed ID: 6109889
    [No Abstract] [Full Text] [Related]

  • 24. Iron chelation in thalassemia: mechanism of desferrioxamine action.
    Hershko C, Rachmilewitz EA.
    Isr J Med Sci; 1978 Nov 24; 14(11):1111-5. PubMed ID: 750535
    [Abstract] [Full Text] [Related]

  • 25. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH, Cerny EA, Wright BJ, Rahman YE.
    J Lab Clin Med; 1983 May 24; 101(5):806-16. PubMed ID: 6403640
    [Abstract] [Full Text] [Related]

  • 26. An improved animal model for studying desferrioxamine.
    Steward A, Williamson I, Madigan T, Bretnall A, Hassan IF.
    Br J Haematol; 1996 Dec 24; 95(4):654-9. PubMed ID: 8982041
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of lipid peroxidation by a new family of iron chelators. Comparison with desferrioxamine.
    Rachidi S, Coudray C, Baret P, Gelon G, Pierre JL, Favier A.
    Biol Trace Elem Res; 1994 Dec 24; 41(1-2):77-87. PubMed ID: 7946911
    [Abstract] [Full Text] [Related]

  • 28. Liposome-encapsulated desferrioxamine in experimental iron overload.
    Lau EH, Cerny EA, Rahman YE.
    Br J Haematol; 1981 Apr 24; 47(4):505-18. PubMed ID: 7213574
    [Abstract] [Full Text] [Related]

  • 29. A novel depot preparation of desferrioxamine-B: development of formulation principles.
    Lowther N, Sparks K, Nicklin J, Jin Y.
    Drug Dev Ind Pharm; 1999 Nov 24; 25(11):1157-66. PubMed ID: 10596353
    [Abstract] [Full Text] [Related]

  • 30. Oral deferiprone for iron chelation in people with thalassaemia.
    Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD004839. PubMed ID: 17636775
    [Abstract] [Full Text] [Related]

  • 31. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ, Johnson DK, Finch CA.
    Br J Haematol; 1982 Oct 18; 52(2):211-24. PubMed ID: 7126464
    [Abstract] [Full Text] [Related]

  • 32. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E, Bianco I, Graziani B, Lerone M, Valente M, Congedo P, Ponzini D, Costantini S.
    Acta Haematol; 1982 Oct 18; 68(2):115-23. PubMed ID: 6812366
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness of oral iron chelators assayed in the rat.
    Kim BK, Huebers HA, Finch CA.
    Am J Hematol; 1987 Mar 18; 24(3):277-84. PubMed ID: 3826055
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Objectives and mechanism of iron chelation therapy.
    Hershko C, Link G, Konijn AM, Cabantchik ZI.
    Ann N Y Acad Sci; 2005 Mar 18; 1054():124-35. PubMed ID: 16339658
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
    Silliman CC, Peterson VM, Mellman DL, Dixon DJ, Hambidge KM, Lane PA.
    J Lab Clin Med; 1993 Jul 18; 122(1):48-54. PubMed ID: 8320490
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.